The following links are provided by IPC for the benefit of its users and members. IPC does not attest to the accuracy of or assume any responsibility for the content or information provided by linked sites, nor does it endorse or recommend any specific content or information contained therein. Please be aware that when you exit the IPC website you are subject to the policies and procedures of the new site.
North American
In the latest Psoriasis Review IPC's bi-annual review of the latest news in the field of psoriasis. read the latest issue
Latest news Commentary: NPF COVID-19 Task Force Guidance StatementsJanuary 06, 2021Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based. IPC Statement on SARS-CoV-2 Vaccines and PsoriasisDecember 02, 2020While the news of a potential SARS-CoV-2 vaccine is to be welcomed, the impact of psoriasis therapy, particularly systemic therapy, on the effectiveness and safety of vaccines needs to be considered. Psoriasis updates in a nutshell: Pathogenesis, markers and therapeuticsNovember 19, 2020Get the latest updates about psoriasis on topics such as pathogenesis, markers and therapeutics from Dr. Mohamed El-Komy in this short IPC video. Are you a dermatologist practicing in the Middle East?November 03, 2020Get the latest news on treating psoriasis in the Middle East with Dr. El Sayed. More News